Umetrics has entered into a global sales partnership with Sartorius Stedim Biotech (SSB), an international pharmaceutical and biotech supplier.
Under the cooperation agreement SSB will embed Umetrics technology into SSB products. SSB will assume global marketing and distribution of the Umetrics portfolio of Chemometrics software for the pharmaceutical and biopharmaceutical industries.
SSB will also integrate Umetrics software programs as private label products into its own bioprocess portfolio and market these as stand-alone solutions under both brands under a dual branding arrangement.
Lars Lindstrom, general manager of Umetrics, said: 'Umetrics stands to benefit from the global sales structures of SSB. Thanks to SSB’s international reach and solid market standing in the biopharma sector, we can gain access to substantially more customers.
'SSB’s integrated solutions with embedded Umetrics MVA and DoE technology will clearly create added value for SSB and our customers. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of Umetrics’ products.'
